ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1159

Mitofusins by Regulating Lung Macrophage-Derived Immune Signals Modulate Monocyte Migration and Interorgan Cross-Talk during Kidney Fibrosis

Session Information

  • CKD: Mechanisms - 3
    October 26, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Bhatia, Divya, Weill Cornell Medicine, New York, New York, United States
  • Patiño, Edwin, Weill Cornell Medicine, New York, New York, United States
  • Kallinos, Eleni, Weill Cornell Medicine, New York, New York, United States
  • Plataki, Maria, Weill Cornell Medicine, New York, New York, United States
  • Choi, Augustine MK, Weill Cornell Medicine, New York, New York, United States
  • Choi, Mary E., Weill Cornell Medicine, New York, New York, United States
Background

Chronic kidney disease (CKD)-associated lung injury is under-recognized. Coexistence of lung dysfunction with CKD increases rates of kidney failure and mortality. We studied alveolar macrophage (AM) and type 2 alveolar epithelial cell (AEC2)-specific roles of mitochondrial fusion proteins, mitofusin (MFN)1 and MFN2 in kidney fibrosis-associated lung injury and interorgan crosstalk.

Methods

Myeloid-(LysM-Cre+/-) or AEC2 (Spc-Cre+/-)-specific Mfn1+/- and/or Mfn2+/- & control mice were subjected to unilateral ureteral obstruction (UUO) or sham surgery (7-days), or adenine or control diet (4 or 8-weeks). Lungs, kidneys, & bronchoalveolar lavage fluid (BALF) were analyzed by western blot, Masson’s trichrome staining, & flow cytometry. Blood was assessed for blood urea nitrogen (BUN), creatinine, chemokine analysis (bead array) & flow cytometry. THP-1 cells were treated with TGF-β1 and/or PGC-1α agonist.

Results

CKD-associated monocyte infiltration in the lungs, AM-derived inflammatory (mitochondrial-specific reactive oxygen species (mROS), Ly6Chigh) & fibrotic (CX3CR1, galectin-3, arginase-I) signals were suppressed in myeloid-specific Mfn1+/- and/or Mfn2+/- mice. Protection in myeloid-specific Mfn1+/- and/or Mfn2+/- mice was mediated by AEC2-specific compensatory inductions of MFN1/MFN2 during CKD. AEC2-specific Mfn1+/- and/or Mfn2+/- mice after UUO had increased monocytes in the lungs and BALF. After UUO, interstitial, monocyte-derived, and tissue-resident alveolar macrophages from lungs and BALF of AEC2-specific Mfn1+/- and/or Mfn2+/- mice displayed increased mROS & galectin-3. AEC2-specific Mfn1+/- and/or Mfn2+/- mice after UUO had increased levels of i) BUN & creatinine, ii) circulating CCL-17, 22, TGF-β1, IL-12p40, & iii) CCR2+, Ly6Chigh, mROS+ monocytes. TGF-β1 promoted, while PGC-1α agonist suppressed migratory, inflammatory, and profibrotic functions of THP-1 monocytes.

Conclusion

Myeloid lineage-specific Mfn1/Mfn2 ablation attenuated CKD-associated lung injury via a compensatory induction of MFN1/MFN2 in AEC2. AEC2-specific loss of Mfn1/Mfn2 accelerated kidney fibrosis-associated lung macrophage-derived local and circulating inflammatory signals. Circulating immune signals by promoting monocytes' infiltration into the kidney, can exaggerate kidney inflammation and fibrosis.

Funding

  • Other NIH Support